Log in
NASDAQ:PTLA

Portola Pharmaceuticals SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$18.03
0.00 (0.00 %)
(As of 07/16/2020)
Add
Compare
Today's Range
$18.03
Now: $18.03
$18.03
50-Day Range
$18.03
MA: $18.03
$18.03
52-Week Range
$5.31
Now: $18.03
$31.73
VolumeN/A
Average Volume3.17 million shs
Market Capitalization$1.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.32

SEC Filings

Portola Pharmaceuticals (NASDAQ:PTLA) SEC Filings

DateFilerForm TypeView
07/13/2020
7:31 AM
Portola Pharmaceuticals (Filer)
Form 15-12B
07/07/2020
2:39 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:41 PM
Portola Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:35 PM
Moriarty John B (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:33 PM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:32 PM
LOVE TED W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:24 PM
Brege Laura (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:22 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
8:22 AM
Portola Pharmaceuticals (Filer)
Form POSASR
07/02/2020
8:19 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:18 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:17 AM
Portola Pharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
07/02/2020
8:16 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:16 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:14 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:12 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:11 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:08 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
8:07 AM
Portola Pharmaceuticals (Filer)
Form S-8 POS
07/02/2020
7:53 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2020
5:07 AM
Portola Pharmaceuticals (Subject)
Form SC 14D9/A
07/02/2020
5:03 AM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-T/A
06/25/2020
8:27 AM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-T/A
06/25/2020
8:26 AM
Portola Pharmaceuticals (Subject)
Form SC 14D9/A
06/24/2020
4:01 PM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-T/A
06/19/2020
8:37 PM
Portola Pharmaceuticals (Subject)
Form SC 14D9/A
06/16/2020
4:01 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:23 PM
Portola Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:15 PM
Portola Pharmaceuticals (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:10 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:06 PM
LOVE TED W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:59 PM
JOHNSON JOHN (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:54 PM
FENTON DENNIS M (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:49 PM
Brege Laura (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
7:30 AM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-T/A
06/15/2020
6:45 AM
Portola Pharmaceuticals (Subject)
Form SC 14D9/A
06/09/2020
9:04 AM
Portola Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
06/08/2020
1:56 PM
Portola Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G/A
06/05/2020
4:23 PM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-T/A
06/01/2020
3:35 PM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-T/A
05/27/2020
7:51 AM
Portola Pharmaceuticals (Subject)
Form SC 14D9
05/27/2020
7:01 AM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-T
05/26/2020
5:08 AM
Portola Pharmaceuticals (Subject)
Form SC14D9C
05/18/2020
3:28 PM
Portola Pharmaceuticals (Filer)
Form DEFA14A
05/11/2020
3:10 PM
Portola Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
3:01 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2020
8:57 AM
Magnetar Financial LLC (Filed by)
Portola Pharmaceuticals (Subject)
Form SC 13D
05/07/2020
4:29 PM
Portola Pharmaceuticals (Subject)
Form SC14D9C
05/07/2020
3:31 PM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-C
05/05/2020
8:30 PM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-C
05/05/2020
4:05 PM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-C
05/05/2020
4:05 PM
Portola Pharmaceuticals (Subject)
Form SC14D9C
05/05/2020
6:23 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2020
6:19 AM
ALEXION PHARMACEUTICALS, INC. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC TO-C
04/09/2020
5:28 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
5:07 AM
Portola Pharmaceuticals (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
03/03/2020
6:02 PM
Patni Rajiv (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:58 PM
Moriarty John B (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:51 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:35 PM
Koenig Sheldon L. (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:26 PM
Moriarty John B (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:22 PM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:14 PM
Garland J. Scott (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:10 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:03 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
3:23 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
8:53 AM
Portola Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
02/11/2020
5:27 PM
Patni Rajiv (Reporting)
Portola Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/10/2020
11:21 AM
Portola Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/10/2020
11:01 AM
Portola Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G
02/07/2020
9:58 AM
Portola Pharmaceuticals (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
02/04/2020
6:03 PM
Moriarty John B (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
6:00 PM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
5:57 PM
Koenig Sheldon L. (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
5:54 PM
Garland J. Scott (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
5:51 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
5:48 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
6:45 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
3:20 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
1:02 PM
Portola Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/21/2019
4:07 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
4:10 PM
Portola Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
6:32 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
6:28 PM
Garland J. Scott (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:16 PM
LOVE TED W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2019
6:06 PM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
6:02 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
5:04 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:46 PM
Portola Pharmaceuticals (Filer)
Form 424B5
08/09/2019
5:51 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
4:14 PM
Portola Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
4:11 PM
Portola Pharmaceuticals (Filer)
Form S-3ASR
08/07/2019
3:12 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
7:06 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:42 PM
Portola Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:36 PM
Portola Pharmaceuticals (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:33 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:26 PM
JOHNSON JOHN (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:19 PM
FENTON DENNIS M (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:14 PM
Brege Laura (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.